The Lancet Regional Health. Americas (Sep 2022)

Leading causes of excess mortality in Mexico during the COVID-19 pandemic 2020–2021: A death certificates study in a middle-income country

  • Lina Sofía Palacio-Mejía,
  • Juan Eugenio Hernández-Ávila,
  • Mauricio Hernández-Ávila,
  • Dwight Dyer-Leal,
  • Arturo Barranco,
  • Amado D. Quezada-Sánchez,
  • Mariana Alvarez-Aceves,
  • Ricardo Cortés-Alcalá,
  • Jorge Leonel Fernández- Wheatley,
  • Iliana Ordoñez-Hernández,
  • Edgar Vielma-Orozco,
  • María de la Cruz Muradás-Troitiño,
  • Omar Muro-Orozco,
  • Enrique Navarro-Luévano,
  • Kathia Rodriguez-González,
  • Jean Marc Gabastou,
  • Ruy López-Ridaura,
  • Hugo López-Gatell

Journal volume & issue
Vol. 13
p. 100303

Abstract

Read online

Summary: Background: The death toll after SARS-CoV-2 emergence includes deaths directly or indirectly associated with COVID-19. Mexico reported 325,415 excess deaths, 34.4% of them not directly related to COVID-19 in 2020. In this work, we aimed to analyse temporal changes in the distribution of the leading causes of mortality produced by COVID-19 pandemic in Mexico to understand excess mortality not directly related to the virus infection. Methods: We did a longitudinal retrospective study of the leading causes of mortality and their variation with respect to cause-specific expected deaths in Mexico from January 2020 through December 2021 using death certificate information. We fitted a Poisson regression model to predict cause-specific mortality during the pandemic period, based on the 2015–2019 registered mortality. We estimated excess deaths as a weekly difference between expected and observed deaths and added up for the entire period. We expressed all-cause and cause-specific excess mortality as a percentage change with respect to predicted deaths by our model. Findings: COVID-19 was the leading cause of death in 2020–2021 (439,582 deaths). All-cause total excess mortality was 600,590 deaths (38⋅2% [95% CI: 36·0 to 40·4] over expected). The largest increases in cause-specific mortality, occurred in diabetes (36·8% over expected), respiratory infections (33·3%), ischaemic heart diseases (32·5%) and hypertensive diseases (25·0%). The cause-groups that experienced significant decreases with respect to the expected pre-pandemic mortality were infectious and parasitic diseases (-20·8%), skin diseases (-17·5%), non-traffic related accidents (-16·7%) and malignant neoplasm (-5·3%). Interpretation: Mortality from COVID-19 became the first cause of death in 2020–2021, the increase in other causes of death may be explained by changes in the health service utilization patterns caused by hospital conversion or fear of the population using them. Cause-misclassification cannot be ruled out. Funding: This study was funded by Conacyt.

Keywords